NASDAQ (US) Website – NASDAQ Investor Overview
beigene
IR Menu

Investor Presentation - February 2023

All Documents

Events

Events & Presentations

Press Releases

Mar 21, 2023
BeiGene Enters New Phase to Expand US Manufacturing and R&D Footprint in New Jersey    read more...
Feb 27, 2023
BeiGene Reports Fourth Quarter and Full Year 2022 Financial Results    read more...
Feb 24, 2023
BeiGene Receives 10th Approval for PD-1 Inhibitor Tislelizumab in China    read more...
Press Releases

INVESTOR RELATIONS +1 857-302-5189

Thank you for your interest in Beigene, Ltd ! You will receive an email shortly. Please confirm your email address by clicking the link inside.

Back to the form